Markus Follmann is an experienced professional in the field of medicinal chemistry, currently serving as Vice President at Bayer since January 2017. Previous roles include Research Scientist at sanofi-aventis from January 2003 to December 2007, and various positions at Bayer, including Senior Research Scientist and Director of Medicinal Chemistry from February 2008 to August 2012. Markus Follmann holds a doctorate in Organic Chemistry, obtained from Johannes Gutenberg University Mainz, where research was conducted under the Kunz Group, and completed a postdoctoral fellowship in Total Synthesis at Scripps Research in the Nicolaou Group.
This person is not in the org chart
This person is not in any teams
This person is not in any offices